Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon on Energy Expenditure in Healthy Obese Subjects
NCT03139305Phase 1Active, not recruiting
- Sponsor
- AdventHealth Translational Research Institute
- Start
- Oct 2017
- Primary completion
- Feb 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of glucagon in obesity (3 arms), sponsored by AdventHealth Translational Research Institute. Primary endpoints: Energy Expenditure at 24 hours and Effects of continuous IV infusion of glucagon versus placebo at 72 hours. Started Oct 2017; status: active, not recruiting.
02
Drugs
glucagon
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03139305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03139305.